TCWP’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

TCWP’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5	Closed	–	–	1883
2022 Q1	$0	Buy	+5	New	+$563	﹤0.01%	1955

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCWP's KRTX Position: Q2 2022 in Review

TCWP sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2022, closing a stake of 5 shares.

TCWP first reported a position in KRTX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 195 funds tracked by Wall St. Rank hold KRTX as of Q2 2022.

TCWP reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
TCWP sold 5 Karuna Therapeutics, Inc. Common Stock shares in Q2 2022.
TCWP first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
TCWP's Karuna Therapeutics, Inc. Common Stock position peaked at $0 in Q1 2022.
195 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.